KR101460815B1 - 관절염 질환 치료의 지속성 효과를 갖는 제약 제제 - Google Patents

관절염 질환 치료의 지속성 효과를 갖는 제약 제제 Download PDF

Info

Publication number
KR101460815B1
KR101460815B1 KR1020097014014A KR20097014014A KR101460815B1 KR 101460815 B1 KR101460815 B1 KR 101460815B1 KR 1020097014014 A KR1020097014014 A KR 1020097014014A KR 20097014014 A KR20097014014 A KR 20097014014A KR 101460815 B1 KR101460815 B1 KR 101460815B1
Authority
KR
South Korea
Prior art keywords
hyaluronic acid
crosslinked
gel
delete delete
crosslinking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020097014014A
Other languages
English (en)
Korean (ko)
Other versions
KR20090087496A (ko
Inventor
겐지 미야모토
게이지 요시오카
가츠야 다카하시
Original Assignee
세이가가쿠 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세이가가쿠 고교 가부시키가이샤 filed Critical 세이가가쿠 고교 가부시키가이샤
Publication of KR20090087496A publication Critical patent/KR20090087496A/ko
Application granted granted Critical
Publication of KR101460815B1 publication Critical patent/KR101460815B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1020097014014A 2006-12-06 2007-12-06 관절염 질환 치료의 지속성 효과를 갖는 제약 제제 Expired - Fee Related KR101460815B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86879806P 2006-12-06 2006-12-06
US60/868,798 2006-12-06
PCT/JP2007/073987 WO2008069348A1 (en) 2006-12-06 2007-12-06 Pharmaceutical agent having long-lasting effect of treating arthritic disorders

Publications (2)

Publication Number Publication Date
KR20090087496A KR20090087496A (ko) 2009-08-17
KR101460815B1 true KR101460815B1 (ko) 2014-11-12

Family

ID=39203191

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097014014A Expired - Fee Related KR101460815B1 (ko) 2006-12-06 2007-12-06 관절염 질환 치료의 지속성 효과를 갖는 제약 제제

Country Status (9)

Country Link
US (3) US8889652B2 (enExample)
EP (3) EP2386306A1 (enExample)
JP (3) JP5291621B2 (enExample)
KR (1) KR101460815B1 (enExample)
CN (2) CN101573123B (enExample)
AU (1) AU2007328871B2 (enExample)
CA (1) CA2672002C (enExample)
TW (2) TWI419697B (enExample)
WO (1) WO2008069348A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016125960A1 (ko) * 2015-02-05 2016-08-11 박재우 연골손상 치료용 조성물 및 이의 제조방법

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI419697B (zh) * 2006-12-06 2013-12-21 Seikagaku Kogyo Co Ltd 治療關節失調之長效藥劑
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم
ITTO20110428A1 (it) * 2011-05-13 2012-11-14 Rottapharm Spa Esteri dell'acido ialuronico, loro preparazione ed uso in dermatologia
JO3564B1 (ar) 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
CN105377899B (zh) * 2013-07-08 2017-12-01 电化株式会社 核壳型交联透明质酸凝胶颗粒、其制造方法和医用材料
US20150133561A1 (en) * 2013-11-12 2015-05-14 Vizuri Health Sciences Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
KR20160002256A (ko) * 2014-06-30 2016-01-07 (주)메디톡스 가교된 히알루론난을 유효성분으로 포함하는 골관절염 치료용 약제학적 조성물 및 그를 이용한 골관절염 치료 방법
KR102357341B1 (ko) * 2014-11-06 2022-02-03 주식회사 엘지생활건강 숙지황 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용
CN114010640A (zh) * 2015-08-19 2022-02-08 爱荷华大学研究基金会 创伤后骨关节炎的预防性治疗
KR101637883B1 (ko) * 2015-09-30 2016-07-21 선바이오(주) 폴리에틸렌글리콜 수화젤 주사제
KR101895950B1 (ko) * 2015-12-18 2018-09-06 (주)한국비엠아이 골관절염 치료를 위한 친수화된 설파살라진 및 히알루론산을 포함하는 조성물 및 이의제조방법
US10925839B2 (en) 2017-03-14 2021-02-23 Seikagaku Corporation Composition for treating joint disease and kit containing same
AR116566A1 (es) 2018-10-03 2021-05-19 Novartis Ag Administración sostenida de polipéptidos similares a la angiopoyetina 3
FR3105729B1 (fr) * 2019-12-31 2023-07-21 Mrs Biotech Composition pour la gestion du poids d’un sujet
CN115444840B (zh) * 2022-09-15 2023-08-25 四川大学 一种前药、两性离子水凝胶及其制备方法、应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6031017A (en) * 1995-11-15 2000-02-29 Seikagaku Corporation Photocured cross-linked-hyaluronic acid gel and method of preparation thereof
US6602859B2 (en) * 2000-12-19 2003-08-05 Seikagaku Corporation Photocurable hyaluronic acid derivative and process for producing the same, and photocured crosslinked-hyaluronic acid derivative and medical material using the same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61210034A (ja) 1985-03-15 1986-09-18 Seikagaku Kogyo Co Ltd 関節症治療剤
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
JPH0574571A (ja) 1990-12-25 1993-03-26 Ricoh Co Ltd 電界発光素子
JP2855307B2 (ja) 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
JP3343181B2 (ja) * 1995-09-20 2002-11-11 生化学工業株式会社 桂皮酸誘導体
US6025444A (en) 1994-11-17 2000-02-15 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Cinnamic acid derivative
US5690961A (en) 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
JP3955107B2 (ja) * 1995-05-01 2007-08-08 生化学工業株式会社 架橋多糖の製造法
PT939086E (pt) 1998-02-27 2004-07-30 Stichting Hippomedics Processo para produzir o acido hialuronico reticulado
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
NZ521079A (en) * 2000-02-03 2004-08-27 Denki Kagaku Kogyo Kk Hyaluronic acid gel, process for producing the same, and medical material containing the same
JP4172176B2 (ja) * 2000-12-19 2008-10-29 生化学工業株式会社 光反応性ヒアルロン酸およびその製造方法ならびに光架橋ヒアルロン酸および医用材料
JP4990446B2 (ja) 2001-05-28 2012-08-01 電気化学工業株式会社 関節症治療用注入剤
JP4958368B2 (ja) 2002-02-28 2012-06-20 電気化学工業株式会社 架橋ヒアルロン酸
EP2287205A3 (en) 2004-09-15 2012-08-01 Seikagaku Corporation Photoreactive polysaccharide. photocrosslinked polysaccharide products, the method of making them and medical materials made therefrom
CA2744999A1 (en) 2004-12-30 2006-07-13 Genzyme Corporation Regimens for intra-articular viscosupplementation
WO2007004675A1 (ja) 2005-07-06 2007-01-11 Seikagaku Corporation 薬剤導入光架橋ヒアルロン酸誘導体ゲル
KR20130109259A (ko) 2005-10-12 2013-10-07 세이가가쿠 고교 가부시키가이샤 점막에 적용하는 작용제 및 그것의 제조 방법
TWI419697B (zh) * 2006-12-06 2013-12-21 Seikagaku Kogyo Co Ltd 治療關節失調之長效藥劑
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6031017A (en) * 1995-11-15 2000-02-29 Seikagaku Corporation Photocured cross-linked-hyaluronic acid gel and method of preparation thereof
US6602859B2 (en) * 2000-12-19 2003-08-05 Seikagaku Corporation Photocurable hyaluronic acid derivative and process for producing the same, and photocured crosslinked-hyaluronic acid derivative and medical material using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Journal of Biomedical Meterials Research. Part A., 70(4), 550-559쪽(2004.09.15.) *
Journal of Biomedical Meterials Research. Part A., 70(4), 550-559쪽(2004.09.15.)*

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016125960A1 (ko) * 2015-02-05 2016-08-11 박재우 연골손상 치료용 조성물 및 이의 제조방법

Also Published As

Publication number Publication date
EP2386306A1 (en) 2011-11-16
CA2672002C (en) 2015-06-02
JP5291621B2 (ja) 2013-09-18
JP2010511596A (ja) 2010-04-15
CN103356694B (zh) 2015-09-02
US8889652B2 (en) 2014-11-18
AU2007328871B2 (en) 2013-11-21
CN101573123B (zh) 2013-06-05
CA2672002A1 (en) 2008-06-12
JP5889976B2 (ja) 2016-03-22
JP2013209417A (ja) 2013-10-10
US20150283169A1 (en) 2015-10-08
JP5600192B2 (ja) 2014-10-01
WO2008069348A1 (en) 2008-06-12
TW200831113A (en) 2008-08-01
HK1185556A1 (en) 2014-02-21
TW201414479A (zh) 2014-04-16
EP2094280A1 (en) 2009-09-02
US20110053885A1 (en) 2011-03-03
TWI528964B (zh) 2016-04-11
EP2910248A1 (en) 2015-08-26
CN101573123A (zh) 2009-11-04
JP2014237704A (ja) 2014-12-18
KR20090087496A (ko) 2009-08-17
AU2007328871A1 (en) 2008-06-12
HK1135923A1 (en) 2010-06-18
WO2008069348A9 (en) 2009-08-20
TWI419697B (zh) 2013-12-21
CN103356694A (zh) 2013-10-23
US9616087B2 (en) 2017-04-11
US20150094280A1 (en) 2015-04-02
US9301972B2 (en) 2016-04-05

Similar Documents

Publication Publication Date Title
KR101460815B1 (ko) 관절염 질환 치료의 지속성 효과를 갖는 제약 제제
KR20130028012A (ko) 관절염 주사요법제
RU2558064C2 (ru) Фармацевтическая композиция для ослабления боли
KR101637883B1 (ko) 폴리에틸렌글리콜 수화젤 주사제
KR102006680B1 (ko) 히알루론산과 마그네슘을 포함하는 골관절염 치료를 위한 안정한 액상 조성물
EP4400125A1 (en) Sol-gel transition of 6-arm peg hydrogel over time
JP2007507516A (ja) アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
JP7506431B2 (ja) ヒアルロン酸とプルロニックを含む関節及び軟骨損傷の予防又は治療用組成物
AU2014200868B2 (en) Pharmaceutical agent having long-lasting effect of treating arthritic disorders
HK1185556B (en) Pharmaceutical agent having long-lasting effect of treating arthritic disorders
HK1135923B (en) Pharmaceutical agent having long-lasting effect of treating arthritic disorders
US20250099598A1 (en) Analgesic Therapeutics Based on Conjugation of Biocompatible Polymers to Ion Channel Modulators
WO2024080954A1 (en) Intra-articular gel for tissue and cartilage regeneration

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20171018

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20181018

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20191016

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20231106

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20231106